FacebookFacebook
TwitterTwitter
DribbleDribble
FacebookFacebook
1312 POSTS
Health Blog

Indore, MP, INDIA

connect@purshology.com

+91-731-6634235

Having A News To Share?

 

☰
Health Blog
HAPPY LIFE

Daron Acemoglu, Simon Johnson and James Robinson win 2024 Nobel Prize in Economics – Healthcare Economist

DiagnosticTest.Pro - Health Analysis - October 15, 2024
DiagnosticTest.Pro
146 views 4 mins 0 Comments

The Nobel Prize committee summarizes their contributions as follows:

Some countries become trapped in a situation with extractive institutions and low economic growth. The introduction of inclusive institutions would create long-term benefits for everyone, but extractive institutions provide short-term gains for the people in power. As long as the political system guarantees they will remain in control, no one will trust their promises of future economic reforms. According to the laureates, this is why no improvement occurs.
However, this inability to make credible promises of positive change can also explain why democratisation sometimes occurs. When there is a threat of revolution, the people in power face a dilemma. They would prefer to remain in power and try to placate the masses by promising economic reforms, but the population are unlikely to believe that they will not return to the old system as soon as the situation settles down. In the end, the only option may be to transfer power and establish democracy.

One book of interest (one I just ordered) is Why Nations Fail: The Origins of Power, Prosperity, and Poverty by Acemoglu and Robinson. Alex Tabarrok of Marginal Revolution called Acemoglu:

…the Wilt Chamberlin of economics, an absolute monster of productivity, who racks up the papers and the citations at nearly unprecedented rates. According to Google Scholar he has 247,440 citations and an H-index of 175, which means 175 papers each with more than 175 citations.

The authors cite the importance of institutions looking at North and South Korea and also cities, like Nogales, than span an international border. The N.Y. Times writes:

As an example, Dr. Acemoglu and Dr. Robinson point to the city of Nogales, which straddles the border between Mexico and Arizona.
Northern Nogales is more affluent than its southern portion, despite a shared culture and location. The driver of differences, the economists argue, is the institutions governing the two halves of the city.

It’s interesting what different media outlines choose to highlight for this award. Some focus on the research. Some focus on the value the researchers placed on democracy. Another article focused the fact the all three laureates are immigrants to the US.

See more coverage on the 2024 Nobel Prize in Economics from other sources: NPR, WSJ, Marginal Revolution, Nobel.

Do you think the prize was deserved or would you have preferred another economist to win the prize? Let me know.

Source link

Disclaimer :

This article is solely for informational purposes, any medical information contained is not a substitute for professional medical advice and readers should not rely on it as such.

If you believe there may be errors or misinformation in this article, we encourage you to contact the webmasters by messaging the provided contact information.

Your feedback is valuable, and we are committed to rectifying any inaccuracies. Please note that the content will be re-evaluated, and corrections will be made as necessary following your submission.

TAGS: #Acemoglu#Daron#Economics#Economist#Healthcare#James#Johnson#Nobel#Prize#Robinson#Simon#win
PREVIOUS
What is microRNA and why did its discovery merit this year’s Nobel Prize for Medicine? – Healthcare Economist
NEXT
Ozempic Face: What You Need to Know
Related Post
August 23, 2024
What are the potential productivity impacts of new medications that treat Medicare beneficiaries? – Healthcare Economist
August 14, 2024
Do State Out-Of-Pocket Caps On Insulin Costs Improve Access? – Healthcare Economist
November 26, 2024
What is HEMA? – Healthcare Economist
October 22, 2025
Patient preferences for attributes of bispecific antibodies for relapse/refractory diffuse large B-cell lymphoma in the US – Healthcare Economist
Leave a Reply

Click here to cancel reply.

Recent Posts

  • Chronic myeloid leukemia treatment intolerance imposes additional resource and economic burden on oncology practices in the United States
  • Celebrating Your Wins: A Year of Reflection
  • LIC Claim Settlement Ratio 2024–2025 (IRDAI Data & 5-Year Trends)
  • Quantifying treatment value under IRA – Healthcare Economist
  • Magma Health Insurance Review 2025

Recent Comments

  1. A WordPress Commenter on Hello world!
  2. John Moore on AB Shirt White Jeans
  3. John Moore on Beanie BeeLogo
  4. John Moore on Shirt Pearl Cream for Men
  5. John Moore on Adventurer DarkBoo

Whether you’re a healthcare professional, patient, or someone interested in learning more about health diagnostics, Diagnostictest.pro is your go-to resource for reliable and up-to-date information. Join us in our mission to promote better health through knowledge and awareness.

FILOSOFI Behind

We strive to make complex medical information accessible to everyone, ensuring that our readers can easily navigate their healthcare journeys.

Scroll To Top
© Copyright 2026 - Health Blog . All Rights Reserved